Wang is an applied microbiologist, working at the interface between microbial genetics and metabolic engineering to develop new microbial production processes.

Dr. Baluch is the KE Biosciences Asst Director and oversees the ALMC, Flow, RegenMed, Histology and SOLS shared core facilities. Her research focuses on cellular behavior using advanced microscopy techniques.

Vermaas and his team conduct basic and applied research on cyanobacteria, a group of photosynthetic microbes, using these organisms as a chassis to produce useful compounds (biofuels, green chemicals) from sunlight and CO2.

Frasch has developed new assays to examine the rotation of single molecules of molecular motor proteins under a microscope.

Mor is a molecular biologist and biochemist whose research focuses on using plants to produce useful and therapeutic polypeptides, proteins and enzymes.

Hugh Mason was the first to publish peer-reviewed work on the use of plants for production of vaccine antigens.

Dr. Shengxi Chen focuses on developing new therapeutic agents for treatment of breast cancers; and developing new detection methods to diagnose dengue and SAR-CoV-2 RNAs . 

Nikkhah's laboratory is currently focused on the integration of innovative biomaterial and microscale technologies to create biomimetic model tissue constructs for regenerative medicine and disease modeling applications.

The Smith group specializes in developing novel imaging technologies and multiomic biomarker discovery towards applications in women’s health and mental illness.